Sept 16 (Reuters) - Guardian Pharmacy Services said on

Monday it was targeting a valuation as much as $973.5 million in

its initial public offering in the United States.

Expectations of an imminent interest rate cut by the U.S.

Federal Reserve is encouraging more companies to press ahead

with their listing plans.

Guardian Pharmacy is aiming to raise as much as $108 million

by offering 6.75 million shares at a price range of $14 to $16

each.

The company plans to list on the New York Stock Exchange

under the symbol "GRDN".

Raymond James, Truist Securities and Stephens Inc are the

underwriters for the offering.